David Kolb, M.B.A.
David is a life science entrepreneur and former investment banker. He has been in the biotech investment field for over two decades having founded four companies and having completed over 70 transactions valued at over $2.5 billion. His current interests include clinical supplements focused on kids, diagnostics for unmet medical needs, cancer metabolism and subcellular targeting. He is a Founding Partner of the life science incubator, Raphael Capital Partners LLC. While serving that role he has founded/created a portfolio of life science companies across the areas of diagnostics and therapeutics in the areas of wound care, CNS, cancer and cardio/metabolic. He is also a Founder and Chairman of the Board for Emunamedica LLC, a non-invasive wound diagnostics company, with the goal of providing wound care diagnostic support for clinicians, to generate better outcomes for patients, in a cost-effective manner for insurance companies and Medicare.